A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF CARBOPLATIN AND AUTOLOGOUS BONE-MARROW SUPPORT

被引:210
作者
SHEA, TC
FLAHERTY, M
ELIAS, A
EDER, JP
ANTMAN, K
BEGG, C
SCHNIPPER, L
FREI, E
HENNER, WD
机构
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,SOLID TUMOR AUTOLOGOUS MARROW PROGRAM,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CANC PHARMACOL,BOSTON,MA 02115
[3] BETH ISRAEL HOSP,BOSTON,MA 02215
关键词
D O I
10.1200/JCO.1989.7.5.651
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:651 / 661
页数:11
相关论文
共 40 条
  • [1] ADAMS M, 1986, 5TH NCI EORTC S AMST
  • [2] ANTMAN K, 1987, CANCER TREAT REP, V71, P119
  • [3] ETOPOSIDE (VP-16) AND CISPLATIN IN PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER - CLINICAL-TRIAL AND INVITRO CORRELATES
    BATIST, G
    CARNEY, DN
    COWAN, KH
    VEACH, SR
    GILLIOM, M
    BUNN, PA
    IHDE, DC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (06) : 982 - 986
  • [4] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II
    CALVERT, AH
    HARLAND, SJ
    NEWELL, DR
    SIDDIK, ZH
    JONES, AC
    MCELWAIN, TJ
    RAJU, S
    WILTSHAW, E
    SMITH, IE
    BAKER, JM
    PECKHAM, MJ
    HARRAP, KR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) : 140 - 147
  • [5] STABILITY OF CISPLATIN, IPROPLATIN, CARBOPLATIN, AND TETRAPLATIN IN COMMONLY USED INTRAVENOUS SOLUTIONS
    CHEUNG, YW
    CRADOCK, JC
    VISHNUVAJJALA, BR
    FLORA, KP
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1987, 44 (01): : 124 - 130
  • [6] TREATMENT OF ADVANCED MALIGNANT-MELANOMA WITH HIGH-DOSE MELPHALAN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    CORNBLEET, MA
    MCELWAIN, TJ
    KUMAR, PJ
    FILSHIE, J
    SELBY, P
    CARTER, RL
    HEDLEY, DW
    CLARK, ML
    MILLAR, JL
    [J]. BRITISH JOURNAL OF CANCER, 1983, 48 (03) : 329 - 334
  • [7] CURT GA, 1983, CANCER RES, V43, P4470
  • [8] DREGMAN CL, 1986, CANCER CHEMOTHER PHA, V18, P117
  • [9] EDER JP, 1986, CANCER RES, V46, P446
  • [10] EDMONSON JH, 1987, CANCER TREAT REP, V71, P199